Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells

M Batten, J Li, S Yi, NM Kljavin, DM Danilenko… - Nature …, 2006 - nature.com
M Batten, J Li, S Yi, NM Kljavin, DM Danilenko, S Lucas, J Lee, FJ de Sauvage, N Ghilardi
Nature immunology, 2006nature.com
Abstract Interleukin 27 (IL-27) was first characterized as a proinflammatory cytokine with T
helper type 1–inducing activity. However, subsequent work has demonstrated that mice
deficient in IL-27 receptor (IL-27Rα) show exacerbated inflammatory responses to a variety
of challenges, suggesting that IL-27 has important immunoregulatory functions in vivo. Here
we demonstrate that IL-27Rα-deficient mice were hypersusceptible to experimental
autoimmune encephalomyelitis and generated more IL-17-producing T helper cells. IL-27 …
Abstract
Interleukin 27 (IL-27) was first characterized as a proinflammatory cytokine with T helper type 1–inducing activity. However, subsequent work has demonstrated that mice deficient in IL-27 receptor (IL-27Rα) show exacerbated inflammatory responses to a variety of challenges, suggesting that IL-27 has important immunoregulatory functions in vivo. Here we demonstrate that IL-27Rα-deficient mice were hypersusceptible to experimental autoimmune encephalomyelitis and generated more IL-17-producing T helper cells. IL-27 acted directly on effector T cells to suppress the development of IL-17-producing T helper cells mediated by IL-6 and transforming growth factor-β. This suppressive activity was dependent on the transcription factor STAT1 and was independent of interferon-γ. Finally, IL-27 suppressed IL-6-mediated T cell proliferation. These data provide a mechanistic explanation for the IL-27-mediated immune suppression noted in several in vivo models of inflammation.
nature.com